Cargando…

Atherosclerosis and cardiac function assessment in low-density lipoprotein receptor-deficient mice undergoing body weight cycling

BACKGROUND: Obesity has become an epidemic in many countries and is supporting a billion dollar industry involved in promoting weight loss through diet, exercise and surgical procedures. Because of difficulties in maintaining body weight reduction, a pattern of weight cycling often occurs (so called...

Descripción completa

Detalles Bibliográficos
Autores principales:	McMillen, T S, Minami, E, LeBoeuf, R C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697407/ https://www.ncbi.nlm.nih.gov/pubmed/23797386 http://dx.doi.org/10.1038/nutd.2013.19

Ejemplares similares

Modulation of adipose tissue lipolysis and body weight by high-density lipoproteins in mice
por: Wei, H, et al.
Publicado: (2014)

Myeloid β-Catenin Deficiency Exacerbates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice
por: Wang, Fang, et al.
Publicado: (2018)

Folic acid delays development of atherosclerosis in low‐density lipoprotein receptor‐deficient mice
por: Pan, Sunlei, et al.
Publicado: (2018)

Low-density lipoprotein particles in atherosclerosis
por: Qiao, Ya-Nan, et al.
Publicado: (2022)

Cysteamine Decreases Low‐Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low‐Density Lipoprotein Receptor–Deficient Mice
por: Ahmad, Feroz, et al.
Publicado: (2021)

High density lipoproteins and atherosclerosis: emerging aspects
por: Sala, Federica, et al.
Publicado: (2012)

High density lipoprotein mimicking nanoparticles for atherosclerosis
por: Chen, Jun, et al.
Publicado: (2020)

Ghrelin Receptor Deficiency does not Affect Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Null Mice
por: Habegger, Kirk M., et al.
Publicado: (2011)

HIV Protein Tat Induces Macrophage Dysfunction and Atherosclerosis Development in Low-Density Lipoprotein Receptor-Deficient Mice
por: Meng, Zhaojie, et al.
Publicado: (2022)

Oxidized low density lipoprotein, stem cells, and atherosclerosis
por: Yang, Hui, et al.
Publicado: (2012)

High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and Atherosclerosis
por: Ossoli, Alice, et al.
Publicado: (2016)

Low-Density Lipoprotein Cholesterol, Structural Atherosclerosis, and Functional Atherosclerosis in Older Japanese
por: Shimizu, Yuji, et al.
Publicado: (2022)

Tesaglitazar ameliorates non-alcoholic fatty liver disease and atherosclerosis development in diabetic low-density lipoprotein receptor-deficient mice
por: ZHANG, BU-CHUN, et al.
Publicado: (2012)

Probucol alleviates atherosclerosis and improves high density lipoprotein function
por: Zhong, Jian-Kai, et al.
Publicado: (2011)

The Role of Oxidized Low-Density Lipoproteins in Atherosclerosis: The Myths and the Facts
por: Maiolino, Giuseppe, et al.
Publicado: (2013)

Mechanistic Insights into the Oxidized Low-Density Lipoprotein-Induced Atherosclerosis
por: Khatana, Chainika, et al.
Publicado: (2020)

Spontaneous severe hypercholesterolemia and atherosclerosis lesions in rabbits with deficiency of low-density lipoprotein receptor (LDLR) on exon 7
por: Lu, Rui, et al.
Publicado: (2018)

Resveratrol protects against diet-induced atherosclerosis by reducing low-density lipoprotein cholesterol and inhibiting inflammation in apolipoprotein E-deficient mice
por: Chang, Geng-Ruei, et al.
Publicado: (2015)

Hepatic paraoxonase 1 ameliorates dysfunctional high-density lipoprotein and atherosclerosis in scavenger receptor class B type I deficient mice
por: Zhao, Xiao-Jie, et al.
Publicado: (2021)

Nonlinear Muscles, Passive Viscoelasticity and Body Taper Conspire To Create Neuromechanical Phase Lags in Anguilliform Swimmers
por: McMillen, T., et al.
Publicado: (2008)

Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis
por: Hermansson, Andreas, et al.
Publicado: (2010)

Utility of Atherosclerosis Imaging in the Evaluation of High-Density Lipoprotein–Raising Therapies
por: Duivenvoorden, Raphaël, et al.
Publicado: (2011)

Porphyromonas gingivalis accelerates atherosclerosis through oxidation of high-density lipoprotein
por: Kim, Hyun-Joo, et al.
Publicado: (2018)

Genetic modulation of diabetic nephropathy among mouse strains with Ins2 Akita mutation
por: Wu, Xiuju, et al.
Publicado: (2014)

Omapatrilat, an Angiotensin-Converting Enzyme and Neutral Endopeptidase Inhibitor, Attenuates Early Atherosclerosis in Diabetic and in Nondiabetic Low-Density Lipoprotein Receptor–Deficient Mice
por: Levy, Zohar, et al.
Publicado: (2003)

Effects of High Fat Feeding and Diabetes on Regression of Atherosclerosis Induced by Low-Density Lipoprotein Receptor Gene Therapy in LDL Receptor-Deficient Mice
por: Willecke, Florian, et al.
Publicado: (2015)

Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR(-/-)) Mice
por: Larmann, Jan, et al.
Publicado: (2015)

Moxonidine Increases Uptake of Oxidised Low-Density Lipoprotein in Cultured Vascular Smooth Muscle Cells and Inhibits Atherosclerosis in Apolipoprotein E-Deficient Mice
por: Wang, Yutang, et al.
Publicado: (2023)

Cysteamine inhibits lysosomal oxidation of low density lipoprotein in human macrophages and reduces atherosclerosis in mice
por: Wen, Yichuan, et al.
Publicado: (2019)

Lipids and Lipoproteins in Atherosclerosis
por: Chroni, Angeliki, et al.
Publicado: (2011)

Lipids and Lipoproteins in Atherosclerosis
por: Bezsonov, Evgeny, et al.
Publicado: (2023)

On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety
Publicado: (1995)

Relationship between Concentration Difference of Different Density Lipoproteins and Shear Stress in Atherosclerosis
por: Meng, Wei, et al.
Publicado: (2012)

Oxidation of Low-Density Lipoprotein by Iron at Lysosomal pH: Implications for Atherosclerosis
por: Satchell, Leanne, et al.
Publicado: (2012)

Rosiglitazone attenuates atherosclerosis and increases high-density lipoprotein function in atherosclerotic rabbits
por: LI, CHEN, et al.
Publicado: (2015)

Infusional high-density lipoproteins therapies as a novel strategy for treating atherosclerosis
por: Di Bartolo, Belinda A., et al.
Publicado: (2016)

The Dual Role of Low-Density Lipoprotein Receptor-Related Protein 1 in Atherosclerosis
por: Chen, Jiefang, et al.
Publicado: (2021)

Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies
por: Jin, Xiao, et al.
Publicado: (2022)

Oxidized low-density lipoprotein associates with cardiovascular disease by a vicious cycle of atherosclerosis and inflammation: A systematic review and meta-analysis
por: Hong, Christin G., et al.
Publicado: (2023)

Lipoprotein sialylation in atherosclerosis: Lessons from mice
por: Yu, Liming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qkucq5snaqrap38ato5dpbfmkk